NCT05061277View on ClinicalTrials.gov

Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Recifercept in Healthy Chinese Participants

PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

October 25, 2023

Primary Completion Date

December 12, 2023

Study Completion Date

June 16, 2024

Conditions

Healthy

Interventions

DRUG

Recifercept

A lyophilized powder for solution for injection

Trial Locations (2)

200040

Huashan Hospital Fudan University, Shanghai

201107

Huashan Hospital Fudan University, Shanghai

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY